Lilly’s retatrutide achieves significant weight loss and A1C reduction in Phase 3 trial
1. Retatrutide met all major Phase 3 endpoints, delivering substantial reductions in both A1C and body weight in patients with...
Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk
1. In the randomized COBRRA trial, apixaban was associated with substantially less clinically relevant bleeding than rivaroxaban in patients with...
Pfizer’s Talzenna combo significantly delays prostate cancer progression
1. The combination of talazoparib and enzalutamide demonstrated a statistically significant improvement in radiographic progression-free survival for metastatic hormone-sensitive prostate...
![2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]](https://www.2minutemedicine.com/wp-content/uploads/2025/05/ChatGPT-Image-May-12-2025-at-10_22_23-AM-350x250.png)
2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]
Pfizer’s Talzenna combo significantly delays progression in frontline prostate cancer Topline results from the Phase 3 TALAPRO-3 study indicate that...
Investigation into “Mommy Makeover” chains prompts national consumer alert
1. A joint investigation into cosmetic surgery chains has uncovered disfiguring injuries and deaths, prompting an urgent warning from plastic...
Landmark ACSM/McMaster guidelines simplify resistance training for longevity
1. The 2026 ACSM guidelines move away from complex exercise prescriptions, emphasizing that any amount of resistance training significantly improves...
NVIDIA GTC 2026 turns healthcare AI into a pop-culture phenomenon
1. Jensen Huang’s GTC 2026 keynote has redefined health care artificial intelligence as essential infrastructure, moving the technology from the...
Susie Wiles’ breast cancer diagnosis drives national screening surge
1. White House Chief of Staff Susie Wiles’ public breast cancer diagnosis is projected to drive a significant short-term increase...
The Scan by 2 Minute Medicine®: Susie Wiles breast cancer diagnosis drives national screening surge, Jensen Huang’s GTC keynote turns healthcare AI into a pop-culture phenomenon, landmark ACSM guidelines simplify resistance training for longevity, and consumer alert issued for high-pressure cosmetic surgery chains
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers....
Shingles vaccine and sildenafil linked to lower Alzheimer’s risk
1. An expert panel identified the shingles vaccine and sildenafil as the top candidates for repurposing to protect against Alzheimer's...
